1005 related articles for article (PubMed ID: 15941063)
21. Human parvovirus b19 infection in patients with coronary atherosclerosis.
Liu SC; Tsai CT; Wu CK; Yu MF; Wu MZ; Lin LI; Wang SS; Hwang JJ; Tseng YZ; Chiang FT; Tseng CD
Arch Med Res; 2009 Oct; 40(7):612-7. PubMed ID: 20082878
[TBL] [Abstract][Full Text] [Related]
22. Serological and virological markers of human parvovirus B19 infection in sera of hemophiliacs.
Grosse-Bley A; Eis-Hübinger AM; Kaiser R; Oldenburg J; Brackmann HH; Schwarz TF; Schneweis KE
Thromb Haemost; 1994 Oct; 72(4):503-7. PubMed ID: 7878623
[TBL] [Abstract][Full Text] [Related]
23. Parvovirus B19 infection in Chile: markers of infection and immunity in patients with clinical symptoms.
Larrañaga C; León O; Díaz P; Miranda M; Norambuena X; Pérez M; Gaggero A
J Med Virol; 2007 Dec; 79(12):1927-34. PubMed ID: 17935173
[TBL] [Abstract][Full Text] [Related]
24. Detection of parvovirus B19 infection in first and second trimester fetal loss.
de Krijger RR; van Elsacker-Niele AM; Mulder-Stapel A; Salimans MM; Dreef E; Weiland HT; van Krieken JH; Vermeij-Keers C
Pediatr Pathol Lab Med; 1998; 18(1):23-34. PubMed ID: 9566279
[TBL] [Abstract][Full Text] [Related]
25. A high prevalence of parvovirus B19 DNA in patients with psoriasis.
Yazici AC; Aslan G; Baz K; Ikizoglu G; Api H; Serin MS; Tezcan S; Emekdas G; Tasdelen B
Arch Dermatol Res; 2006 Oct; 298(5):231-5. PubMed ID: 16862431
[TBL] [Abstract][Full Text] [Related]
26. [Diagnosis of parvovirus B19 infection in hematological patients with partial red cell aplasia of the bone marrow].
Iaguzhinskaia OE; Pivnik AV; Fevraleva IS; Sudarikov AB; Lisovina IuS; Loginova IV; Shitareva IV
Ter Arkh; 2001; 73(8):50-6. PubMed ID: 11599268
[TBL] [Abstract][Full Text] [Related]
27. Parvovirus B19 infection in Taiwanese patients with hematological disorders.
Lee YM; Tsai WH; You JY; Ing-Tiau Kuo B; Liao PT; Ho CK; Hsu HC
J Med Virol; 2003 Dec; 71(4):605-9. PubMed ID: 14556276
[TBL] [Abstract][Full Text] [Related]
28. Human parvovirus B19 infection during pregnancy--value of modern molecular and serological diagnostics.
Enders M; Schalasta G; Baisch C; Weidner A; Pukkila L; Kaikkonen L; Lankinen H; Hedman L; Söderlund-Venermo M; Hedman K
J Clin Virol; 2006 Apr; 35(4):400-6. PubMed ID: 16332455
[TBL] [Abstract][Full Text] [Related]
29. Adaptive immune responses against parvovirus B19 in patients with myocardial disease.
Lindner J; Noutsias M; Lassner D; Wenzel J; Schultheiss HP; Kuehl U; Modrow S
J Clin Virol; 2009 Jan; 44(1):27-32. PubMed ID: 18980860
[TBL] [Abstract][Full Text] [Related]
30. The presence of parvovirus B19 VP and NS1 genes in the synovium is not correlated with rheumatoid arthritis.
Peterlana D; Puccetti A; Beri R; Ricci M; Simeoni S; Borgato L; Scilanga L; Cerù S; Corrocher R; Lunardi C
J Rheumatol; 2003 Sep; 30(9):1907-10. PubMed ID: 12966589
[TBL] [Abstract][Full Text] [Related]
31. [Detection of human parvovirus B19 DNA using PCR and serological test using ELISA for diagnosis of infection].
Saito Y; Ikegaya K; Yano S; Yamauchi T; Hikiji K
Rinsho Byori; 1993 Feb; 41(2):203-8. PubMed ID: 8361022
[TBL] [Abstract][Full Text] [Related]
32. [The use of real-time polymerase chain reaction and enzyme immunoassay for the diagnosis of acute parvovirus B19 infections in immunosuppressed patients].
Işik N; Ağaçfidan A; Ağirbaşli H; Işik DM; Bozkaya E; Gedikoğlu G; Badur S
Mikrobiyol Bul; 2003 Oct; 37(4):277-83. PubMed ID: 14748265
[TBL] [Abstract][Full Text] [Related]
33. Chronic fatigue syndrome after human parvovirus B19 infection without persistent viremia.
Seishima M; Mizutani Y; Shibuya Y; Arakawa C
Dermatology; 2008; 216(4):341-6. PubMed ID: 18277075
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the Roche LightCycler parvovirus B19 quantification kit for the diagnosis of parvovirus B19 infections.
Braham S; Gandhi J; Beard S; Cohen B
J Clin Virol; 2004 Sep; 31(1):5-10. PubMed ID: 15288606
[TBL] [Abstract][Full Text] [Related]
35. [Prevalence of anti-human parvovirus B19 IgG antibody among blood donors in Jilin province].
Wei Q; Li Y; Wang JW; Wang H; Qu JG; Hung T
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Jun; 20(2):60-2. PubMed ID: 16816866
[TBL] [Abstract][Full Text] [Related]
36. Acute human parvovirus B-19 infection in hospitalized children: A serologic and molecular survey.
Miron D; Luder A; Horovitz Y; Izkovitz A; Shizgreen I; Ben David E; Ohnona FS; Schlesinger Y
Pediatr Infect Dis J; 2006 Oct; 25(10):898-901. PubMed ID: 17006284
[TBL] [Abstract][Full Text] [Related]
37. Evidence for persistence of human parvovirus B19 DNA in bone marrow.
Cassinotti P; Burtonboy G; Fopp M; Siegl G
J Med Virol; 1997 Nov; 53(3):229-32. PubMed ID: 9365887
[TBL] [Abstract][Full Text] [Related]
38. [Comparative study of indirect immunofluorescence (IIF) and ELISA techniques in the detection of parvovirus B19].
González M; Hassanhi M; Rivera S; Bracho MP
Invest Clin; 2000 Mar; 41(1):19-27. PubMed ID: 10758696
[TBL] [Abstract][Full Text] [Related]
39. Human parvovirus B19 serology and avidity using a combination of recombinant antigens enables a differentiated picture of the current state of infection.
Pfrepper KI; Enders M; Motz M
J Vet Med B Infect Dis Vet Public Health; 2005; 52(7-8):362-5. PubMed ID: 16316402
[TBL] [Abstract][Full Text] [Related]
40. Prenatal diagnosis of congenital parvovirus B19 infection: value of serological and PCR techniques in maternal and fetal serum.
Dieck D; Schild RL; Hansmann M; Eis-Hübinger AM
Prenat Diagn; 1999 Dec; 19(12):1119-23. PubMed ID: 10590428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
